We are delighted to announce that EFNA has received a charitable donation from Boston Scientific Foundation Europe to support the development of our Neurolytics project. Neurolytics is a survey-facilitation platform that will give patients and caregivers a stronger voice in shaping the future of neurological care.

Through the platform, EFNA’s member associations will be able to create, customise and run multilingual surveys. Due to the systems use of standardised questions and unique ID system, EFNA will be able to aggregate results across countries and conditions.

By capturing lived experiences at scale, the platform will generate shared insights that reveal care gaps, highlight overlooked outcomes, and guide more patient-centred approaches in research, treatment and access.

The Neurolytics platform is now in development and will launch in 2026.